Clinical Trials Directory

Trials / Completed

CompletedNCT02959710

Evaluation of PK of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production

A Phase 1, Pilot, Single-Dose, 3-Way Crossover Study to Compare the Pharmacokinetics of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
16 (estimated)
Sponsor
Cerecin · Industry
Sex
Male
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

To compare serum ketone body (i.e., total ketones, β hydroxybutyrate, and estimate of acetoacetate) levels after single dose administration of AC-1204 mixed in water, AC-1202 mixed in water and AC-1202 mixed in Ensure®.

Conditions

Interventions

TypeNameDescription
DRUGAC-1204 mixed in water40 g AC-1204 (shaken in 240 mL of water) at Hour 0 on Day 1
DRUGAC-1202 mixed in water60 g AC-1202 (shaken in 240 mL of water) at Hour 0 on Day 1
DRUGAC-1202 mixed in Ensure®60 g AC-1202 (shaken in approximately 8 oz \[237 mL of Ensure® Original\] at Hour 0 on Day 1)

Timeline

Start date
2016-11-01
Primary completion
2017-02-01
Completion
2017-04-01
First posted
2016-11-09
Last updated
2017-04-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02959710. Inclusion in this directory is not an endorsement.